| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |